Search research articles
Contact Us
Filters
Showing results (181-190 of 233) with videos related to
Page
of 24
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 28, 2019
Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza
Ching-Tai Huang, Chen-Yiu Hung, Yu-Chia Hseih, et al.
Oncoimmunology
|
December 8, 2018
Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma
Yung-Chang Lin, Chen-Yu Hsu, Sheng-Kai Huang, et al.
Cancer Research
|
January 28, 2012
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells
Li-Yuan Chang, Yung-Chang Lin, Jayashri Mahalingam, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.
Hepatology Communications
|
January 13, 2021
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun-Yen Lin, et al.
Cancer Medicine
|
December 5, 2022
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma
Chung-Wei Su, Wei Teng, Po-Ting Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 4, 2020
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Viruses
|
September 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents
Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng, et al.
International Journal of Legal Medicine
|
October 31, 2021
Spermatozoa identification by the 3-plex MSRE-PCR assay: a collaborative exercise
Kuo-Lan Liu, Li-Chin Tsai, Yu-Chih Lin, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 233) with videos related to
Sort By:
Page
of 24
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 28, 2019
Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza
Ching-Tai Huang, Chen-Yiu Hung, Yu-Chia Hseih, et al.
Oncoimmunology
|
December 8, 2018
Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma
Yung-Chang Lin, Chen-Yu Hsu, Sheng-Kai Huang, et al.
Cancer Research
|
January 28, 2012
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells
Li-Yuan Chang, Yung-Chang Lin, Jayashri Mahalingam, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.
Hepatology Communications
|
January 13, 2021
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun-Yen Lin, et al.
Cancer Medicine
|
December 5, 2022
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma
Chung-Wei Su, Wei Teng, Po-Ting Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 4, 2020
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Viruses
|
September 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents
Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng, et al.
International Journal of Legal Medicine
|
October 31, 2021
Spermatozoa identification by the 3-plex MSRE-PCR assay: a collaborative exercise
Kuo-Lan Liu, Li-Chin Tsai, Yu-Chih Lin, et al.
Page
of 24